Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This ...
Facility-Level Disparities in Radiation Use for Limited-Stage Small Cell Lung Cancer Patient-controlled analgesia (PCA) has been considered for managing cancer pain; however, limited research has been ...